Firalis Molecular Precision Grant Program

in partnership with Vizgen

Vizgen MERSCOPE® Predesigned Panels

Submission deadline : June 30, 2024.
Firalis Molecular Precision is teaming up with Vizgen to offer a Grant Program, awarding the winner with exclusive access to a MERSCOPE® Platform single-cell spatial analysis project leveraging one of Vizgen’s Predesigned Panels.
As part of this grant, the researcher with the most innovative and impactful proposal will have access not only to cutting-edge technology and MERFISH experiments but also to comprehensive data analysis services.
The Vizgen MERSCOPE® Platform stands as the first and only commercial solution for MERFISH technology, revolutionizing single-cell in situ transcriptomic imaging with its massively multiplexed, error-robust capabilities.
Given the intricacies of this advanced technology, specialized expertise is essential for optimal utilization and interpretation of results. Lucky for you (and us!), our genomics team is more than qualified to harness the power of Vizgen’s MERSCOPE® Platform and our bioinformatics team excels in omic data analysis, ensuring deep insights are extracted from complex spatial transcriptomic data.

Terms and conditions:

This program is restricted to researchers in Europe.
Vizgen will provide reagents and Firalis Molecular Precision will conduct MERFISH experiments in-house and provide expert data analysis consultation and support throughout the whole process.
The MERSCOPE Predesigned Panels provide curated lists of biologically relevant genes that enable cell typing and investigation of cellular functional states in Fresh Fixed Frozen and FFPE samples. The leveraged predesigned panels include: PanCancer human panel (500 genes), Liver Tumor human panel (400 genes), Immuno-Oncology human panel (500 genes), PanNeuro mouse panel (500 genes)
The winner will receive MERFISH measurement on 2 FFPE or 4 FF tissue sample replicates.
If the selected winner wishes to run more slides, they will do so at their own expense (additional reagents and services).
Samples cannot exceed 1 cm² per slide.
Deadline for participants to submit a 300-word abstract is June 30, 2024, and winner will be announced and notified in September 2024, after abstracts have been reviewed by an expert committee.

Name *

First

Last

E-mail *

Company name *

Country *

MERSCOPE® Panel *

PanCancer Pathways Panel
Liver Tumor Human Panel
Immuno-oncology Human Panel
PanNeuro Cell Type Mouse Panel

Abstract Title *

Experiment Abstract (up to 300 words) *

Tissue Type *

Sample Type *

FFPE Sample
Fresh Frozen Sample

From time to time, we would like to contact you about our services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick the box below:

I agree to receive other communications from Firalis Molecular Precision.

You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the box below. *

I agree to allow Firalis Molecular Precision to store and process my personal data.

Please tick the box below to indicate your understanding and agreement to cite Firalis Molecular Precision in any publication where you utilize content derived from our services or collaboration, in case you are selected as the grant program winner. *

I understand and agree to cite Firalis Molecular Precision in any publication that includes content derived from their services or collaboration.

Firalis Molecular Precision Grant Program

in partnership with Vizgen

Vizgen MERSCOPE® Predesigned Panels

Terms and conditions:

If you have any question about the Grant Program for our experts

Services

Policies, Terms & Conditions